Cabral AR, Alarcon-Segovia D. Editorial. Will some day PAPS fade into SLE?. Lupus1996 ; 5: 4-5.
2.
Vianna JL et al. Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patients. Am J Med1994; 96: 3-9.
3.
Silver RM et al. Clinical consequences of antiphospholipid antibodies: An historic cohort study. Obstet Gynecol1994; 83: 372-377.
Mujic F. et al. Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. J Rheumatol1995; 22: 1589-1592.
6.
Alarcon-Segovia D. et al. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum1992; 21: 275-286.
7.
Asherson RA, Baguley E., PAL C., Hughes GRV.Antiphospholipid syndrome: 5 years follow-up. Ann Rheum Dis1991; 50: 805-810.
8.
Derksen Rhwm , Gmelig-Meijling FHJ, Groot PHG.Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. Lupus1996 ; 5: 77-80.
9.
Asherson RA et al. The primary antiphospholipid syndrome: Major clinical and serological features. Medicine1989; 68: 366-374.
10.
Piette JS, Wechsler B., Frances C., Godeau P.Systemic lupus erythematosus and the antiphospholipid syndrome: Reflections about the relevance of ARA criteria. J Rheumatol1992; 19: 1835-1837.
11.
Piette JC et al. Exclusion criteria for primary antiphospholipid syndrome. J Rheumatol1993; 20: 1802-1804.